276 related articles for article (PubMed ID: 11468358)
1. Binding of a fibrinogen mimetic stabilizes integrin alphaIIbbeta3's open conformation.
Hantgan RR; Rocco M; Nagaswami C; Weisel JW
Protein Sci; 2001 Aug; 10(8):1614-26. PubMed ID: 11468358
[TBL] [Abstract][Full Text] [Related]
2. The disintegrin echistatin stabilizes integrin alphaIIbbeta3's open conformation and promotes its oligomerization.
Hantgan RR; Stahle MC; Connor JH; Lyles DS; Horita DA; Rocco M; Nagaswami C; Weisel JW; McLane MA
J Mol Biol; 2004 Oct; 342(5):1625-36. PubMed ID: 15364586
[TBL] [Abstract][Full Text] [Related]
3. Effects of ligand-mimetic peptides Arg-Gly-Asp-X (X = Phe, Trp, Ser) on alphaIIbbeta3 integrin conformation and oligomerization.
Hantgan RR; Paumi C; Rocco M; Weisel JW
Biochemistry; 1999 Nov; 38(44):14461-74. PubMed ID: 10545168
[TBL] [Abstract][Full Text] [Related]
4. Dynamic regulation of fibrinogen: integrin αIIbβ3 binding.
Hantgan RR; Stahle MC; Lord ST
Biochemistry; 2010 Nov; 49(43):9217-25. PubMed ID: 20828133
[TBL] [Abstract][Full Text] [Related]
5. The lateral diffusion and fibrinogen induced clustering of platelet integrin αIIbβ3 reconstituted into physiologically mimetic GUVs.
Gaul V; Lopez SG; Lentz BR; Moran N; Forster RJ; Keyes TE
Integr Biol (Camb); 2015 Apr; 7(4):402-11. PubMed ID: 25720532
[TBL] [Abstract][Full Text] [Related]
6. Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling.
Hantgan RR; Stahle MC; Connor JH; Horita DA; Rocco M; McLane MA; Yakovlev S; Medved L
Protein Sci; 2006 Aug; 15(8):1893-906. PubMed ID: 16877710
[TBL] [Abstract][Full Text] [Related]
7. Integrin priming dynamics: mechanisms of integrin antagonist-promoted alphaIIbbeta3:PAC-1 molecular recognition.
Hantgan RR; Stahle MC
Biochemistry; 2009 Sep; 48(35):8355-65. PubMed ID: 19640007
[TBL] [Abstract][Full Text] [Related]
8. Integrin clustering mechanisms explored with a soluble alphaIIbbeta3 ectodomain construct.
Hantgan RR; Gibbs W; Stahle MC; Aster RH; Peterson JA
Biochim Biophys Acta; 2004 Jul; 1700(1):19-25. PubMed ID: 15210121
[TBL] [Abstract][Full Text] [Related]
9. AlphaIIbbeta3 priming and clustering by orally active and intravenous integrin antagonists.
Hantgan RR; Stahle MC; Connor JH; Connor RF; Mousa SA
J Thromb Haemost; 2007 Mar; 5(3):542-50. PubMed ID: 17166246
[TBL] [Abstract][Full Text] [Related]
10. Ligand binding promotes the entropy-driven oligomerization of integrin alpha IIb beta 3.
Hantgan RR; Lyles DS; Mallett TC; Rocco M; Nagaswami C; Weisel JW
J Biol Chem; 2003 Jan; 278(5):3417-26. PubMed ID: 12426312
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic Basis for the Binding of RGD- and AGDV-Peptides to the Platelet Integrin αIIbβ3.
Kononova O; Litvinov RI; Blokhin DS; Klochkov VV; Weisel JW; Bennett JS; Barsegov V
Biochemistry; 2017 Apr; 56(13):1932-1942. PubMed ID: 28277676
[TBL] [Abstract][Full Text] [Related]
12. A CD9, alphaIIbbeta3, integrin-associated protein, and GPIb/V/IX complex on the surface of human platelets is influenced by alphaIIbbeta3 conformational states.
Longhurst CM; White MM; Wilkinson DA; Jennings LK
Eur J Biochem; 1999 Jul; 263(1):104-11. PubMed ID: 10429193
[TBL] [Abstract][Full Text] [Related]
13. β-Subunit Binding Is Sufficient for Ligands to Open the Integrin αIIbβ3 Headpiece.
Lin FY; Zhu J; Eng ET; Hudson NE; Springer TA
J Biol Chem; 2016 Feb; 291(9):4537-46. PubMed ID: 26631735
[TBL] [Abstract][Full Text] [Related]
14. Reversibility versus persistence of GPIIb/IIIa blocker-induced conformational change of GPIIb/IIIa (alphaIIbbeta3, CD41/CD61).
Schwarz M; Katagiri Y; Kotani M; Bassler N; Loeffler C; Bode C; Peter K
J Pharmacol Exp Ther; 2004 Mar; 308(3):1002-11. PubMed ID: 14617694
[TBL] [Abstract][Full Text] [Related]
15. Swing-out of the β3 hybrid domain is required for αIIbβ3 priming and normal cytoskeletal reorganization, but not adhesion to immobilized fibrinogen.
Cheng M; Li J; Negri A; Coller BS
PLoS One; 2013; 8(12):e81609. PubMed ID: 24349096
[TBL] [Abstract][Full Text] [Related]
16. AFM imaging of ligand binding to platelet integrin alphaIIbbeta3 receptors reconstituted into planar lipid bilayers.
Hussain MA; Agnihotri A; Siedlecki CA
Langmuir; 2005 Jul; 21(15):6979-86. PubMed ID: 16008412
[TBL] [Abstract][Full Text] [Related]
17. Conformation-Specific Blockade of αIIbβ3 by a Non-RGD Peptide to Inhibit Platelet Activation without Causing Significant Bleeding and Thrombocytopenia.
Shen C; Liu M; Tian H; Li J; Xu R; Mwangi J; Lu Q; Hao X; Lai R
Thromb Haemost; 2020 Oct; 120(10):1432-1441. PubMed ID: 32717755
[TBL] [Abstract][Full Text] [Related]
18. Antibodies causing thrombocytopenia in patients treated with RGD-mimetic platelet inhibitors recognize ligand-specific conformers of αIIb/β3 integrin.
Bougie DW; Rasmussen M; Zhu J; Aster RH
Blood; 2012 Jun; 119(26):6317-25. PubMed ID: 22490676
[TBL] [Abstract][Full Text] [Related]
19. Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to purified integrin alphaIIbbeta3: evidence for a common binding site for cyclic arginyl-glycinyl-aspartic acid peptides and nonpeptides.
Wong A; Hwang SM; Johanson K; Samanen J; Bennett D; Landvatter SW; Chen W; Heys JR; Ali FE; Ku TW; Bondinell W; Nichols AJ; Powers DA; Stadel JM
J Pharmacol Exp Ther; 1998 Apr; 285(1):228-35. PubMed ID: 9536015
[TBL] [Abstract][Full Text] [Related]
20. A new functional role of the fibrinogen RGD motif as the molecular switch that selectively triggers integrin alphaIIbbeta3-dependent RhoA activation during cell spreading.
Salsmann A; Schaffner-Reckinger E; Kabile F; Plançon S; Kieffer N
J Biol Chem; 2005 Sep; 280(39):33610-9. PubMed ID: 15955823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
